TLANDO 112.5 MG Oral Capsule
- RxCUI
- 2599060
- RxNorm name
- TLANDO 112.5 MG Oral Capsule
- Display name
- TLANDO 112.5 MG Oral Capsule
- Full name
- TLANDO 112.5 MG Oral Capsule
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:57
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tlando | TESTOSTERONE UNDECANOATE | Verity Pharmaceuticals Inc. | 4b0b92e9-6d3c-a0e5-e1c7-342999f72580 | 2026-02-25 | Warnings, Adverse reactions | 2599060 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 4b0b92e9-6d3c-a0e5-e1c7-342999f72580 | TLANDO 112.5 MG Oral Capsule | PSN | 5 | These highlights do not include all the information needed to use TLANDO ® safely and effectively. See full prescribing information for TLANDO. TLANDO (testosterone undecanoate) capsules, for oral use, CIII Initial U.S. Approval: 1953 | 20260225 |
| 4b0b92e9-6d3c-a0e5-e1c7-342999f72580 | Tlando 112.5 MG Oral Capsule | SY | 5 | These highlights do not include all the information needed to use TLANDO ® safely and effectively. See full prescribing information for TLANDO. TLANDO (testosterone undecanoate) capsules, for oral use, CIII Initial U.S. Approval: 1953 | 20260225 |
| 4b0b92e9-6d3c-a0e5-e1c7-342999f72580 | testosterone undecanoate 112.5 MG Oral Capsule [Tlando] | SBD | 5 | These highlights do not include all the information needed to use TLANDO ® safely and effectively. See full prescribing information for TLANDO. TLANDO (testosterone undecanoate) capsules, for oral use, CIII Initial U.S. Approval: 1953 | 20260225 |